As informed in Stock Exchange Announcement No. 5/2007 the Board of Directors of Coloplast has decided to initiate a share buy-back programme in the order of DKK 1 billion during 2007 and part of 2008. A first buy-back programme within the scope of the authority will be exercised in the period from 5 March 2007 to 15 August 2007. The volume of trading in own shares will be limited to a maximum total market value of DKK 500 million. This programme is expected to be followed by an additional programme in August 2007. Under the programme the following transactions have been executed during the period 16.7.07- 20.7.07 (see enclosed PDF).
Recommended Reading
-
The contract is awarded for products that bring improvement to the healthcare industry. Coloplast, a global medical device company and market leader in intimate healthcare, has received an Innovative...
Read More -
Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower...
Read More